Anbio Biotechnology (NNNN)
Designs and distributes diagnostic products for laboratory, point-of-care, and home-use settings.
$5.59
vs last close−0.09 (−1.58%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 0.16% | 71.9K shares | |
|---|---|---|---|
| 12 holders · as of Jun 30, 2026 | |||
| Other | 99.84% | 43.82M shares | |
| remainder | |||
43.89M company shares as of Sep 13, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
12 holders · 71.9K shares · 6 new positions · 8 increased · 3 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 26.7K | 0.06% | +973 | Aug 12, 2026 |
| Bank of America Corp /DE/ | 13.4K | 0.03% | +13.4Knew | Aug 14, 2026 |
| BNP Paribas Arbitrage, SNC | 11.8K | 0.03% | +1.4K | Aug 13, 2026 |
| Marshall Wace, LLP | 11.5K | 0.03% | +11.5Knew | Aug 13, 2026 |
| Morgan Stanley | 7.2K | 0.02% | −107 | Aug 13, 2026 |
| UBS Group AG | 828 | 0.00% | −5.5K | Aug 13, 2026 |
| Eversource Wealth Advisors, LLC | 187 | 0.00% | −79 | Jul 24, 2026 |
| Advisor Group Holdings, Inc. | 77 | 0.00% | +77new | Aug 14, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.